Comparison	O
of	O
therapy	B:C0087111
persistence	O
for	O
fixed	O
versus	O
free	O
combination	O
antihypertensives	B:C0003364
:	O
a	O
retrospective	B:C2985505
cohort	I:C2985505
study	I:C2985505

The	O
aim	O
of	O
the	O
study	B:C2603343
was	O
to	O
compare	O
therapy	B:C0087111
persistence	O
among	O
patients	O
who	O
started	O
with	O
one	O
of	O
three	O
drug	B:C0013227
regimens	B:C0040808
:	O
a	O
monotherapy	B:C0087111
,	O
or	O
combination	O
therapy	B:C0087111
either	O
as	O
a	O
fixed	O
combination	B:C0013162
(	O
ie	O
,	O
'	O
single	O
pill	B:C0994475
')	O
or	O
as	O
a	O
free	O
combination	B:C0013162
(	O
ie	O
,	O
two	O
separate	O
antihypertensive	B:C0003364
agents	I:C0003364
)	O
.	O

In	O
a	O
secondary	O
data	O
analysis	O
,	O
we	O
used	O
descriptive	O
statistics	O
and	O
multivariate	B:C0206031
logistic	I:C0206031
regression	I:C0206031
to	O
measure	O
the	O
effect	O
of	O
the	O
three	O
therapy	B:C0087111
regimens	B:C0040808
on	O
therapy	B:C0087111
persistence	O
over	O
4	O
years	O
.	O

Prescription	B:C1521941
data	I:C1521941
from	O
a	O
large	O
German	B:C1708333
statutory	I:C1708333
health	I:C1708333
insurance	I:C1708333
provider	I:C1708333
.	O

All	O
patients	O
who	O
started	O
with	O
a	O
new	O
antihypertensive	B:C0003364
therapy	B:C0087111
in	O
2007	O
or	O
2008	O
(	O
n=8032	O
)	O
were	O
included	O
and	O
followed	O
for	O
4	O
years	O
.	O

Therapy	B:C0087111
persistence	O
,	O
defined	O
as	O
receiving	O
a	O
refill	O
prescription	B:C1521941
no	O
later	O
than	O
within	O
180	O
days	O
.	O

The	O
persistence	O
rates	O
after	O
4	O
years	O
were	O
nearly	O
identical	O
among	O
patients	O
who	O
started	O
with	O
a	O
monotherapy	B:C0087111
(	O
40.3	O
%	O
)	O
or	O
a	O
fixed	O
combination	B:C0013162
of	O
two	O
drugs	B:C0013227
(	O
39.8	O
%	O
)	O
.	O

However	O
,	O
significantly	O
more	O
patients	O
who	O
started	O
with	O
free	O
-	O
drug	B:C0013162
combinations	I:C0013162
remained	O
therapy	B:C0087111
persistent	O
(	O
56.4	O
%	O
)	O
,	O
resulting	O
in	O
an	O
OR	O
of	O
2.00	O
(	O
95	O
%	O
CI	O
1.6	O
to	O
2.5	O
;	O
p<0.0001	O
)	O
for	O
free	O
combinations	B:C0013162
versus	O
fixed	O
combinations	B:C0013162
.	O

This	O
trend	O
was	O
observed	O
in	O
all	O
age	O
groups	O
and	O
for	O
men	B:C0025266
and	O
women	B:C0043210
.	O

At	O
the	O
end	O
of	O
the	O
study	B:C2603343
period	O
,	O
the	O
number	O
of	O
different	O
antihypertensive	B:C0003364
agents	I:C0003364
was	O
still	O
similar	O
between	O
patients	O
who	O
started	O
with	O
a	O
fixed	O
combination	B:C0013162
(	O
2.41	O
)	O
and	O
patients	O
who	O
started	O
with	O
a	O
free	O
combination	B:C0013162
(	O
2.28	O
)	O
.	O

While	O
single	O
-	O
pill	B:C0994475
combination	B:C0013162
s	O
make	O
it	O
easier	O
to	O
take	O
different	O
drugs	B:C0013227
at	O
once	O
,	O
the	O
risk	O
is	O
high	O
that	O
these	O
several	O
substances	O
are	O
stopped	O
at	O
once	O
.	O

Therapy	B:C0087111
persistence	O
was	O
significantly	O
better	O
for	O
patients	O
who	O
started	O
with	O
a	O
free	O
-	O
drug	B:C0013162
combination	I:C0013162
without	O
taking	O
much	O
fewer	O
different	O
antihypertensive	B:C0003364
drugs	I:C0003364
as	O
those	O
with	O
a	O
fixed	O
combination	B:C0013162
.	O

